CompoAtlas

Ginkgo biloba Bacopa

Food supplement declared in France, declaration No 2020-12-1512

Ginkgo biloba Bacopa is a food supplement declared in France. Status: retrait du marché annoncé pour le 20 August 2027. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Laboratoires VITARMONYL
Status
Retrait du marché annoncé pour le 20 August 2027
Form
Comprimé
Daily dose
2 comprimés
Directions for use
à avaler avec un verre d'eau
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Concentration

Declaration 172118, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Bacopa monnieri (L.) Wettst.FeuilleExtrait sec hydroalcoolique225 mg
Ginkgo biloba L.FeuilleExtrait sec hydroalcoolique120 mg

Additives

E420, E341, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Une consommation excessive peut avoir des effets laxatifs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line